2014, Number 3
<< Back Next >>
Revista Cubana de Cirugía 2014; 53 (3)
Epidermoid carcinoma of the anal margin against the quality of life
Reyes AMA, Beltrán PI, Navarro GY, Suárez RJJ
Language: Spanish
References: 18
Page: 289-295
PDF size: 118.80 Kb.
ABSTRACT
The quality of life of patients should be always borne in mind since it represents the
final outcome of medical performance from the viewpoint of the patient. Occasionally,
this is the only element that we have at our disposal to make therapeutic decisions in
order to manage certain diseases such as terminal epidermoid carcinoma of the anal
margin. The treatment and the behavior for palliative care are aimed at improving the
quality of life of these patients. This is the case of 48 years-old male who went to the
doctor´s because he presented with anal injure that prevents him from seating. After
making all the necessary tests to arrive to a final diagnosis (epidermoid carcinoma of
the anus), to assess him and to indicate the required treatment according to the extent
of disease, we realized that the radical treatment would not change his condition and
then we decided to apply palliative treatment to improve his quality of life. Some
patients come to this service, and after being fully examined, they are diagnosed with
advanced disease. From this moment on, our medical thinking should change to direct
our efforts to the improvement of their quality of life rather than to guide them to a
stormy end to reverse the progression of a disease that has no regression.
REFERENCES
Eisen GM, Locke GR, Provenzale D. Health-Related Quality of Life: a primer for gastroenterologists. Am J Gastroenterol. 1999;94:2017-21.
Stewart AL, Geenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. JAMA. 1989;262:907-13.
Quality of life theory I. The IQOL theory: an integrative theory of the global quality of life concept. Sci World J. 2003;3:1030-40.
Karnosfsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. En: Maclead CM, editor. Evaluation of chemotherapeutic agents. New York: Columbia. 1947; p. 37-56.
Human papillomavirus-associated cancers united states, 2004-2008. MMWR Morb Mortal Wkly Rep. 2012;61:258-61.
Machalek DA , Poynten M, Jin F. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and metaanalysis. Lancet Oncol. 2012;13:487-500.
Wentzensen N. screening for anal cancer: endpoints need. Lancet Oncol. 2012;13:438-40.
Palesfsky J, Berry JM, Jay N. Anal screening. Lancet Oncol. 2012;13:e279-80.
Silverberg MJ , Lau B, Justice AC, Engels E, Gill MJ. Risk of anal cancer in HIV infected and HIV uninfected individuals in North America. Clin Infect Dis. 2012 Apr;54(7):1026-34. doi: 10.1093/cid/cir1012. Epub. 2012 Jan 30.
Siegel R, Naishadham D, Jemal A. Cancer statistics. 2013. Ca: Cancer Journal for Clin. 2013;62:10-29.
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics. CA Cancer Jr Clin. 2014;64:9-29.
Gervaz P, Allal AS, Villiger P, Büibler L, Morel P. Squamous cell carcinoma of the anus: another sexually transmitted disease. Swiss Med Wkly. 2003;133:353-9.
Ryan DP, Comptom CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med. 2000;11:792-8.
Steele SR, Varma MG, Melton GB. Practice parameters for anal squamous neoplasms. Dis Colon Rectum. 2012;55:735-49.
Corti M, Villafañe MF, Marona E, Lewi D. Anal squamous carcinoma: a new AIDSdefining cancer? Case report and literature review. Rev Inst Med Trop. Sao Paulo. 2012;54(6):345-8.
Ryan DP, Mayer RJ. Anal carcinoma: histology, staging, epidemiology, treatment. Curr Opin Oncol. 2000;12:345-52.
Tang LH, Berln J, Branton P. Protocol for the examination of specimens from patients with carcinoma of the anus. 2012 [Citado abril 2014]. Disponoble en: http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2013
Barroso IF. Anal cancer screening. Lancet Oncol. 2012;13:e278-29
Full text